Search results
24 sty 2023 · Learn how David Fitting beat the odds and is thriving 20 years after a glioblastoma brain cancer diagnosis. Discover the secrets to his positive mindset and read his reflection on surviving GBM, featured in our Warrior Wednesday segment and international outlet, Newsweek.
23 gru 2019 · Recent reports edged closer to the secret of long-term survival in patients with glioblastoma (GBM) by analyzing comprehensive genomic and epigenomic chara.
15 lip 2020 · Meta-analyses of real-world data suggested a doubling of 2- and 3-year survival in glioblastoma patients since 2005. However, 5-year survival remains poor with no apparent improvement.
8 lut 2024 · Glioblastoma (GBM) is the most aggressive primary brain malignancy with <45% living a year beyond diagnosis. Previously published investigations of long-term survivors (LTS) provided clinical data but rarely incorporated a comprehensive clinical and molecular analysis.
19 cze 2019 · This is the largest study to date evaluating the factors associated with long-term survival in patients with GBM. By leveraging the NCDB, this study benefits from significant power and the availability of numerous clinical data points.
30 cze 2021 · Glioblastoma multiforme (GBM) is an aggressive tumor that has a poor prognosis with a median survival of 15 months with treatment and 3-4 months without treatment. Subsets of patients are found to survive longer than two years, some survivors lived more than 10 years, and rare cases survived 20 years or more with treatment.
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant, primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic heterogeneity, and protection by the blood brain barrier (BBB) have posed great treatment challenges.
